胃肠道肿瘤分子诊断的临床相关性:ESDO专家讨论与推荐
本文为ESDO专家讨论与推荐,旨在综述胃肠道肿瘤各类分子检测的现状及其临床常规应用意义。专家就预设问题讨论并形成推荐,同时评述分析前变异并提出生物样本质量控制建议。文章总结了专家委员会关于不同胃肠道肿瘤预后与预测分子遗传生物标志物的推荐,以辅助临床决策。
要点
- 综述胃肠道肿瘤分子检测现状及临床常规应用意义。
- 专家讨论形成推荐,并评述分析前变异与质控建议。
- 总结预后与预测分子标志物推荐以辅助临床决策。
核心结论
- 文章总结了专家委员会关于不同胃肠道肿瘤预后与预测分子遗传生物标志物的推荐。
- 所制定的简要全面指南旨在辅助临床医生日常实践中的决策过程。
研究设计与样本
- 由不同国籍、按科学价值选出的意见领袖和专家回答预设问题,并在全体会议上讨论后报告。
- 文章为专家讨论与立场文件,提供临床专业知识与更新循证医学的平衡反映。
主要发现
- 专家就当前医学文献中描述和争议的预设分子遗传生物标志物在不同胃肠道肿瘤中进行了辩论。
- 在可能的情况下制定了临床常规实践推荐。
- 对分析前变异进行了评论,并提出了生物样本质量控制建议。
临床怎么用
- 所制定的指南旨在辅助临床医生在日常临床实践中的决策过程。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND SCOPE: In the epoch of precision medicine and personalised oncology, which aims to deliver the right treatment to the right patient, molecular genetic biomarkers are a topic of growing interest. The aim of this expert discussion and position paper is to review the current status of various molecular tests for gastrointestinal (GI) cancers and especially considering their significance for the clinical routine use. METHODOLOGY: Opinion leaders and experts from diverse nationalities selected on scientific merit were asked to answer to a prepared set of questions about the current status of molecular diagnostics in different GI cancers. All answers were then discussed during a plenary session and reported here in providing a well-balanced reflection of both clinical expertise and updated evidence-based medicine. RESULTS: Preselected molecular genetic biomarkers that are described and disputed in the current medical literature in different GI cancers were debated, and recommendations for clinical routine practice were made whenever possible. Furthermore, the preanalytical variations were commented and proposals for quality controls of biospecimens were made. CONCLUSION: The current article summarises the recommendations of the expert committee regarding prognostic and predictive molecular genetic biomarkers in different entities of GI cancers. The briefly and comprehensively formulated guidelines should assist clinicians in the process of decision making in daily clinical practice.
引用
- Baraniskin A, Van Laethem JL, Wyrwicz L, et al. Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona. Eur J Cancer. 2017. PMID: 29065378. doi:10.1016/j.ejca.2017.09.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。